Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anthracycline-based antibody drug conjugates having high in vivo tolerability

Anthracycline-based antibody drug conjugates having high in vivo tolerability

US Patent 10758556 · Granted Sep 1, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Human antibodies binding to ROR22025
Human antibodies binding to ROR22025
Anthracycline-based antibody drug conjugates having high in vivo tolerability2024
Anthracycline-based antibody drug conjugates having high in vivo tolerability2024
Anthracycline-based antibody drug conjugates having high in vivo tolerability2024
Method of producing an immunoligand/payload conjugate2024
Method of producing an immunoligand/payload conjugate2024
Anti-ROR1 antibodies2023
Anti-ROR1 antibodies2023
Binding protein drug conjugates comprising anthracycline derivatives2023
Binding protein drug conjugates comprising anthracycline derivatives2023
Human antibodies binding to ROR22022